fda glp-1 compounding warning october 2025 National Hispanic Medical Association | After compounded drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA is short-sighted on compounding

Another common stimulant, bitter orange, causes jitteriness or nervousness, increased heart rate, heart palpitations, and elevated blood pressure

For those just starting their GLP-1 journey, these early symptoms and side effects can be jarring and ultimately derail proper use of the drugor even deter potential new patients

At three, six, nine and 12 months following semaglutide initiation, women using hormone therapy experienced approximately 30% greater total body weight loss than the non-hormone therapy users

It focuses on increasing protein, maintaining healthy fats and fiber, and choosing whole, nutrient-dense, minimally processed foods.

Most people regain weight and lose metabolic benefits after stopping